Serveur d'exploration Stress et Covid - Analysis (2020)

Index « Titre (en) » - entrée « inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibition < inhibitors < initial  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000181 (2020) Gianluca Trifir [Italie] ; Salvatore Crisafulli [Italie] ; Giuseppe And [Italie] ; Giorgio Racagni [Italie] ; Filippo Drago [Italie]Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
000216 (2020) Muthiah Vaduganathan ; Orly Vardeny ; Thomas Michel ; John J. V. Mcmurray ; Marc A. Pfeffer ; Scott D. SolomonRenin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
000542 (2020) Noura M. Seleem [Égypte] ; Hemat K. Abd El Latif [Égypte] ; Moataz A. Shaldam [Égypte] ; Amira El-Ganiny [Égypte]Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
000553 (2020) Sejin Jung [Corée du Sud] ; Nam Gu Yoon [Corée du Sud] ; Sujae Yang [Corée du Sud] ; Darong Kim [Corée du Sud] ; Won Seok Lee [Corée du Sud] ; Ki Bum Hong [Corée du Sud] ; Changwook Lee [Corée du Sud] ; Byoung Heon Kang [Corée du Sud] ; Ji Hoon Lee [Corée du Sud] ; Soosung Kang [Corée du Sud]Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.
000566 (2020) Krishnappa Ramya [Inde] ; Ramalingam Suresh [Inde] ; Honnavalli Yogish Kumar [Inde] ; B. R. Prashantha Kumar [Inde] ; N. B. Sridhara Murthy [Inde]Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
000752 (2020) Fabrizio Dal Moro [Italie] ; Ugolino Livi [Italie]Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
000760 (2020) Erkan Cure [Turquie] ; Medine Cumhur Cure [Turquie]Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "inhibitors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021